Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Geron Stock Is Jumping Today

TheMotleyFool

0 0

Shares of the clinical-stage biotech Geron (NASDAQ: GERN) are up by 10.4% as of 9:46 a.m EDT. The spark?

Geron's shares are jumping this morning on the news that the Food and Drug Administration granted the company's sole drug candidate, imetelstat, Fast Track designation as a potential treatment for patients with intermediate-2 or high-risk myelofibrosis (MF) whose disease has relapsed after or is refractory to janus kinase (JAK) inhibitor treatment or relapsed/refractory MF.

Image Source: Getty Images.

Source Fool.com

Like: 0

GERN

Share